An emerging place for lung cancer genomics in 2013

Journal of Thoracic Disease

Volumn 5, Issue SUPPL.5, 2013, Pages

  Daniels, Marissa G ^a   Bowman, Rayleen V ^a   Yang, Ian A ^a   Govindan, Ramaswamy ^b   Fong, Kwun M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genomics; High throughput nucleotide sequencing; Lung neoplasms; Non small cell lung carcinoma (NSCLC); small cell lung carcinoma (SCLC)

Indexed keywords

MICRORNA; TRANSCRIPTOME;

BIOINFORMATICS; CHROMATIN IMMUNOPRECIPITATION; DNA DETERMINATION; DNA METHYLATION; EPIGENETICS; EXOME; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; HIGH THROUGHPUT SEQUENCING; HUMAN; LUNG CANCER; PERSONALIZED MEDICINE; PROTEIN DNA INTERACTION; REVIEW; TREND STUDY; TUMOR GENE;

EID: 84903556056     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2013.10.06     Document Type: Review

References (62)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide Lyon, France: International Agency for Research on Cancer, 2010. Available online: http://globocan.iarc.fr
2. Lung cancer: a global scourge. Lancet 2013;382:659.
3. Cancer survival and prevalence in Australia: Cancers diagnosed from 1982-2004. Canberra: Australian Institute of Health and Welfare; Cancer Australia; The Australasian Association of Cancer Registries, July 2008. Report No.: Contract No.: Sept 12.
4. Parikh P, Puri T. Personalized medicine: Lung Cancer leads the way. Indian J Cancer 2013;50:77-9.
5. Sanger F, Coulson AR. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol 1975;94:441-8.
6. Maxam AM, Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci U S A 1977;74:560-4.
7. Reddy EP, Reynolds RK, Santos E, et al. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 1982;300:149-52.
8. Dulbecco R. A turning point in cancer research: sequencing the human genome. Science 1986;231:1055-6.
9. The International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004;431:931-45.
10. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
11. Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008;456:66-72.
12. Marx V. Next-generation sequencing: The genome jigsaw. Nature 2013;501:263-8.
13. Ross JS, Cronin M. Whole cancer genome sequencing by next-generation methods. Am J Clin Pathol 2011;136:527-39.
14. Mardis ER. A decade's perspective on DNA sequencing technology. Nature 2011;470:198-203.
15. Lander ES. Initial impact of the sequencing of the human genome. Nature 2011;470:187-97.
16. Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 2010;11:685-96.
17. Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copynumber alteration across human cancers. Nature 2010;463:899-905.
18. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310:644-8.
19. Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007;448:561-6.
20. Paez JG, Jänne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-500.
21. Weir BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007;450:893-8.
22. Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010;363:1693-703.
23. Daniels M, Goh F, Wright CM, et al. Whole genome sequencing for lung cancer. J Thorac Dis 2012;4:155-63.
24. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol 2008;26:1135-45.
25. Wheeler DA, Srinivasan M, Egholm M, et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 2008;452:872-6.
26. Campbell PJ, Stephens PJ, Pleasance ED, et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 2008;40:722-9.
27. Hodges E, Xuan Z, Balija V, et al. Genome-wide in situ exon capture for selective resequencing. Nat Genet 2007;39:1522-7.
28. Sugarbaker DJ, Richards WG, Gordon GJ, et al. Transcriptome sequencing of malignant pleural mesothelioma tumors. Proc Natl Acad Sci U S A 2008;105:3521-6.
29. Morin RD, O'Connor MD, Griffith M, et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 2008;18:610-21.
30. Ordway JM, Budiman MA, Korshunova Y, et al. Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS One 2007;2:e1314.
31. Robertson G, Hirst M, Bainbridge M, et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 2007;4:651-7.
32. Yuille M. Infrastructure vital to genome success. Nature 2011;471:166.
33. Kan Z, Jaiswal BS, Stinson J, et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010;466:869-73.
34. Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455:1069-75.
35. Tanaka H, Yanagisawa K, Shinjo K, et al. Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res 2007;67:6007-11.
36. Liu P, Morrison C, Wang L, et al. Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis 2012;33:1270-6.
37. Ju YS, Lee WC, Shin JY, et al. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res 2012;22:436-45.
38. Lee W, Jiang Z, Liu J, et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 2010;465:473-7.
39. Wu K, Huang RS, House L, et al. Next-generation sequencing for lung cancer. Future Oncol 2013;9:1323-36.
40. Pleasance ED, Stephens PJ, O'Meara S, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010;463:184-90.
41. Imielinski M, Berger AH, Hammerman PS, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 2012;150:1107-20.
42. Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012;489:519-25.
43. Govindan R, Ding L, Griffith M, et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 2012;150:1121-34.
44. Systems/Sequencing Systems/A sequencer for every need. Every Budget. Every lab.: Illumina; 2013 [cited 2013 Sept 14]. Available online: http:// www.illumina.com/systems/sequencing.ilmn
45. Systems/Genome Analyzer IIx/Specifications: Illumina Inc.; 2013 [cited 2013 Sept 14]. Available online: http://www.illumina.com/systems/ genome_analyzer_iix/performance_specifications.ilmn
46. [5500] Series Genetic Analysis Systems. In: Technologies L, eds. Carlsbad CA: Life Technologies, 2011.
47. Sequencing Video: The Genome Analyzer: Illumina, 2009
48. Quail MA, Kozarewa I, Smith F, et al. A large genome center's improvements to the Illumina sequencing system. Nat Methods 2008;5:1005-10.
49. Applications/Sequencing/DNA Sequencing/Whole-Genome Sequencing: Illumina Inc.; 2013 [cited 2013 Sept 14]. Available online: http:// www.illumina.com/applications/sequencing/dna_sequencing/whole_ genome_sequencing.ilmn
50. Technology/Moleculo Technology: Illumina Inc.; 2013 [cited 2013 Sept 14]. Available online: http://www.illumina.com/technology/moleculotechnology. ilmn
51. Dressman D, Yan H, Traverso G, et al. Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc Natl Acad Sci U S A 2003;100:8817-22.
52. Drmanac R, Sparks AB, Callow MJ, et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 2010;327:78-81.
53. Wilkerson MD, Yin X, Hoadley KA, et al. Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types. Clin Cancer Res 2010;16:4864-75.
54. Quail MA, Smith M, Coupland P, et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics 2012;13:341.
55. Kirby A, Gnirke A, Jaffe DB, et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet 2013;45:299-303.
56. Kim D, Kim WY, Lee SY, et al. Revising a personal genome by comparing and combining data from two different sequencing platforms. PLoS One 2013;8:e60585.
57. Mardis ER, Ding L, Dooling DJ, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009;361:1058-66.
58. Vignot S, Frampton GM, Soria JC, et al. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer. J Clin Oncol 2013;31:2167-72.
59. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
60. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
61. Green ED, Guyer MS, National Human Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature 2011;470:204-13.
62. Leary RJ, Sausen M, Diaz LA Jr, et al. Cancer detection using wholegenome sequencing of cell free DNA. Oncotarget 2013;4:1119-20.